Spatial frequency domain correlation mapping optical coherence tomography for nanoscale structural characterization
Date
2019-09-16Author
Alexandrov, Sergey
McNamara, Paul M.
Das, Nandan
Zhou, Yi
Lynch, Gillian
Hogan, Josh
Leahy, Martin
Metadata
Show full item recordUsage
This item's downloads: 236 (view details)
Cited 6 times in Scopus (view citations)
Recommended Citation
Alexandrov, Sergey, McNamara, Paul M., Das, Nandan, Zhou, Yi, Lynch, Gillian, Hogan, Josh, & Leahy, Martin. (2019). Spatial frequency domain correlation mapping optical coherence tomography for nanoscale structural characterization. Applied Physics Letters, 115(12), 121105. doi: 10.1063/1.5110459
Published Version
Abstract
Most of the fundamental pathological processes in living tissues exhibit changes at the nanoscale. Noninvasive, label-free detection of structural changes in biological samples pose a significant challenge to both researchers and healthcare professionals. It is highly desirable to be
able to resolve these structural changes, during physiological processes, both spatially and temporally. Modern nanoscopy largely requires
labeling, is limited to superficial 2D imaging, and is generally not suitable for in vivo applications. Furthermore, it is becoming increasingly
evident that 2D biology often does not translate into the real 3D situation. Here, we present a method, spatial frequency domain correlation
mapping optical coherence tomography (sf-cmOCT), for detection of depth resolved nanoscale structural changes noninvasively. Our
approach is based on detection and correlation of the depth resolved spectra of axial spatial frequencies of the object which are extremely
sensitive to structural alterations. The presented work describes the principles of this approach and demonstrates its feasibility by monitoring
internal structural changes within objects, including human skin in vivo. Structural changes can be visualized at each point in the sample in
space from a single image or over time using two or more images. These experimental results demonstrate possibilities for the study of nanoscale structural changes, without the need for biomarkers or labels. Thus, sf-cmOCT offers exciting and far-reaching opportunities for early
disease diagnosis and treatment response monitoring, as well as a myriad of applications for researchers.